News and Analysis

Immunomic Therapeutics scores $61.3m

Immunomic Therapeutics Inc, a biotechnology company focused on nucleic acid immunotherapy platforms, has raised $61.3 million in financing

-

Immunomic Therapeutics Inc, a biotechnology company focused on nucleic acid immunotherapy platforms, has raised $61.3 million in financing. HLB Co., LTD led the round.

Source: Press Release